Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.
This study has been completed.
Merck Sharp & Dohme Corp.
Rennes University Hospital
Information provided by (Responsible Party):
First received: May 9, 2006
Last updated: September 3, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||March 2013|
|Primary Completion Date:||February 2013 (Final data collection date for primary outcome measure)|